Molecular Templates Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Molecular Templates Inc 's ROA in the second quarter of 2024?
Molecular Templates Inc recorded a cumulative net loss of $-48 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -144.53%.

However, within the Healthcare sector 923 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2024 quarter, so far to 4813, from total ROA ranking in the first quarter of 2024 at 4870.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	-26.07 %	-65.46 %	-62.39 %	-62.83 %	-74.79 %
Y / Y Net Income Change	-	-94.73 %	-	-83.14 %	-
Net Income (TTM) in million	-48	-51	-41	26	47
Return On Assets (TTM)	-144.53 %	-142.93 %	-84.12 %	40.96 %	56.55 %
MTEM's Total Ranking	# 4813	# 4870	# 5367	# 96	# 60
Total Assets (TTM) in million	26	27	37	44	36
Seq. Total Assets Change	-3.19 %	-26.07 %	-16.74 %	24.07 %	-54.76 %
Seq. Net Income Change	-	-	-	-	-

MTEM's 5 Years Annual ROA >> Back to MTEM Management Effectiveness >> Compare MTEM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 441
Sector	# 924
Overall	# 4728

Return On Assets Statistics
High	Average	Low
129.04 %	8.37 %	-145.46 %
(Sep 30 2016)		(Jun 30 2024)

Financial Statements
Molecular Templates Inc 's Assets	$ 26 million	MTEM's Balance sheet
Molecular Templates Inc 's Income	$ -8 million	Quarterly MTEM's Income Statement
MTEM's Income by Division		See MTEM's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-63.73 %	-49.29 %	37.82 %	-19.88 %	24.29 %
Total Assets in million	35	98	192	140	174
Y / Y Net Income Change	-91.24 %	11.7 %	-20.88 %	51.13 %	129.21 %
Net Income in million	8	93	83	105	69
Annual Return On Assets	22.96 %	95.05 %	43.15 %	75.17 %	39.85 %

MTEM's 5 Years Annual ROA >> Back to MTEM Management Effectiveness >> Compare MTEM ROA to its Competitors

Comment on MTEM's ROA in the fiscal year ending 2023

In the fiscal year 2023 Molecular Templates Inc 's ROA decreased compared to previous year to 22.96 %, due to deterioration of net income -91.24 % to $8.12 million, from $92.72 million a year ago, as MTEM's assets were $35.38 million.

More Return On Assets Ratios
MTEM's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MTEM's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MTEM's Competitors
Subscribers only: Roa for Molecular Templates Inc 's Suppliers
Subscribers only: Return On Assets for MTEM's Customers

You may also want to know
MTEM's Roi	MTEM's Inventory Turnover Ratio	MTEM's Growth Rates	MTEM's Dividend Comparisons
	MTEM's Profitability Ratios	MTEM's Asset Turnover Ratio	MTEM's Dividend Growth
MTEM's Roe	MTEM's Valuation Ratios	MTEM's Financial Strength Ratios	MTEM's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.